Published in Cancer Immunol Immunother on January 29, 2003
Biomedical Nanomagnetics: A Spin Through Possibilities in Imaging, Diagnostics, and Therapy. IEEE Trans Magn (2010) 3.07
Magnetic nanomaterials for hyperthermia-based therapy and controlled drug delivery. Adv Drug Deliv Rev (2011) 2.23
Application of hyperthermia induced by superparamagnetic iron oxide nanoparticles in glioma treatment. Int J Nanomedicine (2011) 1.48
Nanoparticle delivery systems in cancer vaccines. Pharm Res (2010) 1.20
Immunotherapy of malignant brain tumors. Immunol Rev (2008) 1.20
Physical modalities inducing immunogenic tumor cell death for cancer immunotherapy. Oncoimmunology (2015) 1.02
Effects of titanium dioxide nanoparticle aggregate size on gene expression. Int J Mol Sci (2010) 1.02
Hyperthermic treatment of DMBA-induced rat mammary cancer using magnetic nanoparticles. Biomagn Res Technol (2008) 1.02
Cell-delivered magnetic nanoparticles caused hyperthermia-mediated increased survival in a murine pancreatic cancer model. Int J Nanomedicine (2012) 0.97
Nanoparticles for hyperthermic therapy: synthesis strategies and applications in glioblastoma. Int J Nanomedicine (2014) 0.87
Antibody-mediated targeting of iron oxide nanoparticles to the folate receptor alpha increases tumor cell association in vitro and in vivo. Int J Nanomedicine (2015) 0.83
Combined magnetic nanoparticle-based microRNA and hyperthermia therapy to enhance apoptosis in brain cancer cells. Small (2014) 0.81
Abscopal antitumor immune effects of magnet-mediated hyperthermia at a high therapeutic temperature on Walker-256 carcinosarcomas in rats. Oncol Lett (2014) 0.80
Enhancing therapeutic efficacy through designed aggregation of nanoparticles. Biomaterials (2014) 0.80
Cryo-thermal therapy elicits potent anti-tumor immunity by inducing extracellular Hsp70-dependent MDSC differentiation. Sci Rep (2016) 0.77
Hyperthermia treatment of tumors by mesenchymal stem cell-delivered superparamagnetic iron oxide nanoparticles. Int J Nanomedicine (2016) 0.77
Dendritic-Tumor Fusion Cell-Based Cancer Vaccines. Int J Mol Sci (2016) 0.76
Melanoma-Targeted Chemothermotherapy and In Situ Peptide Immunotherapy through HSP Production by Using Melanogenesis Substrate, NPrCAP, and Magnetite Nanoparticles. J Skin Cancer (2013) 0.76
Identification of collaboration patterns of dysfunctional pathways in breast cancer. Int J Clin Exp Pathol (2014) 0.75
Hyperthermia mediated by dextran-coated La0.7Sr0.3MnO3 nanoparticles: in vivo studies. Int J Nanomedicine (2016) 0.75
Single-molecule imaging analysis of Ras activation in living cells. Proc Natl Acad Sci U S A (2004) 2.84
Medical application of functionalized magnetic nanoparticles. J Biosci Bioeng (2005) 2.81
Intraoperative tractography and motor evoked potential (MEP) monitoring in surgery for gliomas around the corticospinal tract. World Neurosurg (2010) 2.13
Selective propofol injection into the M1 segment of the middle cerebral artery (MCA Wada test) reduces adverse effects and enhances the reliability of the Wada test for determining speech dominance. World Neurosurg (2011) 2.04
Immunoglobulin G4-related lung disease: CT findings with pathologic correlations. Radiology (2009) 1.75
Total tau protein in cerebrospinal fluid and diffusion-weighted MRI as an early diagnostic marker for Creutzfeldt-Jakob disease. Dement Geriatr Cogn Disord (2007) 1.72
Impact of artificial sunlight therapy on the progress of non-alcoholic fatty liver disease in rats. J Hepatol (2010) 1.67
Related transplantation with HLA-1 Ag mismatch in the GVH direction and HLA-8/8 allele-matched unrelated transplantation: a nationwide retrospective study. Blood (2011) 1.65
Risk of aneurysmal rupture: the importance of neck orifice positioning-assessment using computational flow simulation. Neurosurgery (2008) 1.61
Magnetite nanoparticle-loaded anti-HER2 immunoliposomes for combination of antibody therapy with hyperthermia. Cancer Lett (2004) 1.58
Peptide-pulsed dendritic cell vaccination targeting interleukin-13 receptor α2 chain in recurrent malignant glioma patients with HLA-A*24/A*02 allele. Cytotherapy (2012) 1.55
A novel method of intracranial injection via the postglenoid foramen for brain tumor mouse models. J Neurosurg (2011) 1.45
P-wave signal-averaged electrocardiogram for predicting atrial arrhythmia after cardiac surgery. Ann Thorac Surg (2005) 1.43
Long-term survival in patients with newly diagnosed primary central nervous system lymphoma treated with dexamethasone, etoposide, ifosfamide and carboplatin chemotherapy and whole-brain radiation therapy. Leuk Lymphoma (2011) 1.43
Pathologic and biological assessment of lung tumors showing ground-glass opacity. Ann Thorac Surg (2006) 1.42
Thermotherapy using magnetic cationic liposomes powerfully suppresses prostate cancer bone metastasis in a novel rat model. Prostate (2013) 1.41
Fetal and postnatal development of Ca2+ transients and Ca2+ sparks in rat cardiomyocytes. Cardiovasc Res (2003) 1.38
Papillary glioneuronal tumor with a high proliferative component and minigemistocytes in a child. Neuropathology (2014) 1.38
Cancer immunotherapy based on intracellular hyperthermia using magnetite nanoparticles: a novel concept of "heat-controlled necrosis" with heat shock protein expression. Cancer Immunol Immunother (2005) 1.37
Molecular and cellular biology of Borna disease virus infection. Microbes Infect (2002) 1.34
Hidden Markov model-based prediction of antigenic peptides that interact with MHC class II molecules. J Biosci Bioeng (2002) 1.31
IFN-beta down-regulates the expression of DNA repair gene MGMT and sensitizes resistant glioma cells to temozolomide. Cancer Res (2005) 1.27
Intradural cranial chordoma. World Neurosurg (2009) 1.27
Lymph nodes harbor viral reservoirs that cause rebound of plasma viremia in SIV-infected macaques upon cessation of combined antiretroviral therapy. Virology (2011) 1.26
Reovirus apoptosis and virulence are regulated by host cell membrane penetration efficiency. J Virol (2007) 1.24
Current trends in targeted therapies for glioblastoma multiforme. Neurol Res Int (2012) 1.23
Borna disease virus and infection in humans. Front Biosci (2002) 1.21
Tissue engineering using magnetite nanoparticles and magnetic force: heterotypic layers of cocultured hepatocytes and endothelial cells. Tissue Eng (2004) 1.20
Tumor regression by combined immunotherapy and hyperthermia using magnetic nanoparticles in an experimental subcutaneous murine melanoma. Cancer Sci (2003) 1.19
Endovascular treatment strategy for direct carotid-cavernous fistulas resulting from rupture of intracavernous carotid aneurysms. AJNR Am J Neuroradiol (2003) 1.18
Intravenously transplanted human neural stem cells migrate to the injured spinal cord in adult mice in an SDF-1- and HGF-dependent manner. Neurosci Lett (2007) 1.18
Benefits of interferon-β and temozolomide combination therapy for newly diagnosed primary glioblastoma with the unmethylated MGMT promoter: A multicenter study. Cancer (2010) 1.18
The effect of RGD peptide-conjugated magnetite cationic liposomes on cell growth and cell sheet harvesting. Biomaterials (2005) 1.17
Central-pair-linked regulation of microtubule sliding by calcium in flagellar axonemes. J Cell Sci (2003) 1.17
Glioma-initiating cells and molecular pathology: implications for therapy. Brain Tumor Pathol (2011) 1.17
Crystal structure of reovirus attachment protein σ1 in complex with sialylated oligosaccharides. PLoS Pathog (2011) 1.17
A phase I trial of vaccination of CA9-derived peptides for HLA-A24-positive patients with cytokine-refractory metastatic renal cell carcinoma. Clin Cancer Res (2006) 1.15
Dimeric tetrathiafulvalene linked to pseudo-ortho-[2.2]paracyclophane: chiral electrochromic properties and use as a chiral dopant. Chem Asian J (2014) 1.15
Long-term stimulation of the subthalamic nucleus in hemiparkinsonian rats: neuroprotection of dopaminergic neurons. J Neurosurg (2004) 1.14
EGFR mutations in patients with brain metastases from lung cancer: association with the efficacy of gefitinib. Neuro Oncol (2006) 1.11
The global DNA methylation surrogate LINE-1 methylation is correlated with MGMT promoter methylation and is a better prognostic factor for glioma. PLoS One (2011) 1.11
Anti-cancer effect of hyperthermia on breast cancer by magnetite nanoparticle-loaded anti-HER2 immunoliposomes. Breast Cancer Res Treat (2008) 1.10
The relationship between venous hypertension and expression of vascular endothelial growth factor: hemodynamic and immunohistochemical examinations in a rat venous hypertension model. Surg Neurol (2007) 1.10
Anticancer effect and immune induction by hyperthermia of malignant melanoma using magnetite cationic liposomes. Melanoma Res (2003) 1.10
The DNA demethylating agent 5-aza-2'-deoxycytidine activates NY-ESO-1 antigenicity in orthotopic human glioma. Int J Cancer (2008) 1.09
Reovirus mu2 protein inhibits interferon signaling through a novel mechanism involving nuclear accumulation of interferon regulatory factor 9. J Virol (2008) 1.09
Management of subsolid nodules. Chest (2013) 1.09
Antitumor effects of combined therapy of recombinant heat shock protein 70 and hyperthermia using magnetic nanoparticles in an experimental subcutaneous murine melanoma. Cancer Immunol Immunother (2003) 1.09
Retrovirally engineered T-cell-based immunotherapy targeting type III variant epidermal growth factor receptor, a glioma-associated antigen. Cancer Sci (2010) 1.08
Effective cell-seeding technique using magnetite nanoparticles and magnetic force onto decellularized blood vessels for vascular tissue engineering. J Biosci Bioeng (2007) 1.06
SCL/TAL1 interrupting locus derepresses GLI1 from the negative control of suppressor-of-fused in pancreatic cancer cell. Cancer Res (2008) 1.06
Complete regression of mouse mammary carcinoma with a size greater than 15 mm by frequent repeated hyperthermia using magnetite nanoparticles. J Biosci Bioeng (2003) 1.06
4-S-Cysteaminylphenol-loaded magnetite cationic liposomes for combination therapy of hyperthermia with chemotherapy against malignant melanoma. Cancer Sci (2007) 1.06
Enzymological analysis of mutant protein kinase Cgamma causing spinocerebellar ataxia type 14 and dysfunction in Ca2+ homeostasis. J Biol Chem (2008) 1.06
Identification of novel candidate genes for treatment response to risperidone and susceptibility for schizophrenia: integrated analysis among pharmacogenomics, mouse expression, and genetic case-control association approaches. Biol Psychiatry (2009) 1.06
Identification of specific autoantigens in Sjögren's syndrome by SEREX. Immunology (2005) 1.05
Suppression of secondary generalization of limbic seizures by stimulation of subthalamic nucleus in rats. J Neurosurg (2005) 1.04
Activation of JAK/STAT signalling in neurons following spinal cord injury in mice. J Neurochem (2006) 1.04
Morphology-based prediction of osteogenic differentiation potential of human mesenchymal stem cells. PLoS One (2013) 1.04
A carbohydrate recognition-based drug delivery and controlled release system using intraperitoneal macrophages as a cellular vehicle. Cancer Res (2006) 1.04
Artificial neural network approach for selection of susceptible single nucleotide polymorphisms and construction of prediction model on childhood allergic asthma. BMC Bioinformatics (2004) 1.03
Quantitative metabolome analysis profiles activation of glutaminolysis in glioma with IDH1 mutation. Tumour Biol (2014) 1.02
Interferon-beta gene therapy for cancer: basic research to clinical application. Cancer Sci (2004) 1.02
Hyperthermic treatment of DMBA-induced rat mammary cancer using magnetic nanoparticles. Biomagn Res Technol (2008) 1.02
A role of activated Sonic hedgehog signaling for the cellular proliferation of oral squamous cell carcinoma cell line. Biochem Biophys Res Commun (2004) 1.02
Forkhead box A1 transcriptional pathway in KRT7-expressing esophageal squamous cell carcinomas with extensive lymph node metastasis. Int J Oncol (2010) 1.01
Hyperthermia using magnetite cationic liposomes for hamster osteosarcoma. Biomagn Res Technol (2004) 1.01
Modification of endothelial nitric oxide synthase through AMPK after experimental subarachnoid hemorrhage. J Neurotrauma (2009) 1.01
Ureterosciatic hernia successfully treated by ureteral stent placement. Int J Urol (2011) 1.01
Construction and harvest of multilayered keratinocyte sheets using magnetite nanoparticles and magnetic force. Tissue Eng (2004) 1.00
Heat shock protein 70 gene therapy combined with hyperthermia using magnetic nanoparticles. Cancer Gene Ther (2003) 1.00